Cleanrooms — Standards & Technology
A concentrated course providing the attendee an opportunity to get and keep right up to date with essential standards and best practice for cleanrooms intended for life sciences applications.
8 February 2011 – MWB Business Exchange, London ref. M2-2011
17 May 2011 – Regus Edinburgh, Edinburgh ref. M5-2011
Fee: £395 + VAT
Click here to register: London http://www.management-forum.co.uk/gxp/eventid/1467
Edinburgh http://www.management-forum.co.uk/gxp/eventid/1470
Contact:
Andrea James:
andrea.james@management-forum.co.uk
Website:
www.management-forum.co.uk
Tel.
+44 (0) 1483 730071
Training Outcomes
- Understanding best cleanroom practice.
- Preparing for and keeping up to date with forthcoming changes in standards and regulations.
- Identify realistic cost and energy saving opportunities.
Focus
A concentrated course providing the attendee an opportunity to get and keep right up to date with essential standards and best practice for cleanrooms intended for life sciences applications.
- Review of current cleanroom classification requirements and use of BS/EN/ISO 14644-1 and 2.
- A heads up on the revision of ISO 14644-1 & 2. The new statistical model.
- Best practice for air filtration.
- Cleanroom monitoring.
- Integration with The GMPs for sterile products. Impact on industry.
- Sustainable design and operation of cleanrooms and clean air devices.
Who Should Attend?
Cleanroom users in manufacturing and research.
- Specifiers, consultants, and project managers.
- Suppliers and installation firms
- QA and QC professionals
- Certification and test houses.
- Validation personnel.
Trainer
Gordon Farquharson, a Chartered Engineer with more than 30 years experience in quality and safety engineering systems used by the pharmaceutical and life sciences industry. He is a cleanroom expert, is convenor of ISO TC 209, and has been active in the revision of the EU, PIC/S, and WHO GMPs for sterile products.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
